Silencing the intestinal GUCY2C tumor suppressor axis requires

Authors

• Amanda M Pattison
• Joshua R Barton
• Ariana A Entezari
• Alicja Zalewski
• Jeff A Rappaport
• Adam E Snook
• Scott A Waldman

Publication/Presentation Date

9-1-2020

Abstract

Most sporadic colorectal cancer reflects acquired mutations in the adenomatous polyposis coli (

Volume

21

Issue

9

First Page

799

Last Page

805

ISSN

1555-8576

Published In/Presented At

Pattison, A. M., Barton, J. R., Entezari, A. A., Zalewski, A., Rappaport, J. A., Snook, A. E., & Waldman, S. A. (2020). Silencing the intestinal GUCY2C tumor suppressor axis requires APC loss of heterozygosity. Cancer biology & therapy, 21(9), 799–805. https://doi.org/10.1080/15384047.2020.1779005

Disciplines

Business Administration, Management, and Operations | Health and Medical Administration | Management Sciences and Quantitative Methods

PubMedID

32594830

Department(s)

Administration and Leadership

Document Type

Article